Cited by 1,014Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchPrion Diseases and Protein Misfolding

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Open access

Burdick, D, Soreghan, B, Kwon, M, Kosmoski, J, Knauer, M, Henschen, A, Yates, J, Cotman, C, Glabe, C·1992·Journal of Biological Chemistry

DOI 10.1016/s0021-9258(18)48529-8

Open this paper in CoChat — free account

Abstract

The amyloid A4 or beta peptide is a major component of extracellular amyloid deposits that are a characteristic feature of Alzheimer's disease. We synthesized a series of peptide analogs of the A4/beta peptide which are progressively longer at their carboxyl termini, including 42- and 39-residue peptides which represent the major forms of the A4/beta peptide in senile plaque and the hereditary cerebral hemorrhage with amyloidosis form, respectively. All peptides tested, beta 1-28 through beta 1-42, formed amyloid-like fibrils and previously unreported thin sheet-like structures which stained with thioflavin T and Congo Red. The solubility of beta 1-42 and shorter peptides was pH and concentration dependent, with a broad insolubility profile in the pH range of 3.5-6.5 and at concentrations above 0.75 mg/ml. Only peptides of 42 residues or longer were significantly insoluble at pH 7.4. beta 1-47 and beta 1-52 peptides are highly insoluble in aqueous media but are soluble at 40 mg/ml in the alpha helix-promoting solvent, 1,1,1,3,3,3-hexafluoro-2-propanol. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed that the beta 1-42 peptide migrates as a series of higher molecular mass aggregates whereas shorter peptides migrate as monomers. Aggregation is also dependent on pH, peptide concentration, and time of incubation in aqueous medium. These results indicate that the length of the hydrophobic carboxyl terminus of the A4/beta peptide is important in determining the s…

Integrity signals

Registry

Crossref · 10.1016/s0021-9258(18)48529-8

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Cleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,403
Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
Weidemann, A., König, G., Bunke, D., Fischer, P. Q., Salbaum, J. M., Masters, C. L., & Beyreuther, K. T. (1989) · Cell · doi:10.1016/0092-8674(89)90177-3 · Cited by 1,233
Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity
Kitaguchi, N., Takahashi, Y., Tokushima, Y., Shiojiri, S., & Ito, H. (1988) · Nature · doi:10.1038/331530a0 · Cited by 1,083
Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction
Sarin, V. K., Kent, S. B. H., Tam, J. P., & Merrifield, R. B. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90704-1 · Cited by 1,066
A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors
Ponte, P. A., Gonzalez‐DeWhitt, P. A., Schilling, J., Miller, J., Hsu, D. K., Greenberg, B., Davis, K. L., Wallace, W., Lieberburg, I. M., Fuller, F. H., et al. (1988) · Nature · doi:10.1038/331525a0 · Cited by 1,050

Show all 42 references

Research works printed but not linked: 4

Beyreuther, 1986, Discoveries Neurosci., 3, 68
Glabe, 1990, Technique, 2, 138
Joachim, 1989, Am. J. Pathol., 135, 309
Masters, 1987, Ciba Found. Symp., 126, 49

Sorted by citations

Items 301–400 of 1,000

The Metal Loading Ability of β-Amyloid N-Terminus: A Combined Potentiometric and Spectroscopic Study of Copper(II) Complexes with β-Amyloid(1−16), Its Short or Mutated Peptide Fragments, and Its Polyethylene Glycol (PEG)-ylated Analogue
Damante, C. A., Ösz, K., Nagy, Z., Pappalardo, G., Grasso, G., Impellizzeri, G., Rizzarelli, E., & Sóvágó, I. (2008) · Inorganic Chemistry · doi:10.1021/ic8006052 · Cited by 94
Residue-Specific pKaMeasurements of the β-Peptide and Mechanism of pH-Induced Amyloid Formation
Ma, K., Clancy, E. L., Zhang, Y., Ray, D. G., Wollenberg, K., & Zagorski, M. G. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990864o · Cited by 94
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9063-4 · Cited by 93
Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration
Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 95
Fibril Formation and Neurotoxicity by a Herpes Simplex Virus Glycoprotein B Fragment with Homology to the Alzheimer's Aβ Peptide
Cribbs, D. H., Azizeh, B. Y., Cotman, C. W., & LaFerla, F. M. (2000) · Biochemistry · doi:10.1021/bi000029f · Cited by 93
Self-citation
Light scattering analysis of fibril growth from the amino-terminal fragment beta(1–28) of beta-amyloid peptide
Shen, C. L., Scott, G., Merchant, F., & Murphy, R. M. (1993) · Biophysical Journal · doi:10.1016/s0006-3495(93)81312-2 · Cited by 93
β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices
Arias, C., Arrieta, I., & Tapia, R. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410416 · Cited by 96
Synthesis, aggregation, and neurotoxicity of the alzheimer's Aß1-42 amyloid peptide and its isoaspartyl isomers
Fukuda, H., Shimizu, T., Nakajima, M., Mori, H., & Shirasawa, T. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00121-3 · Cited by 92
AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
Kisilevsky, R., Fraser, P. E., & Benson, M. D. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082674 · Cited by 92
Withanolide A and Asiatic Acid Modulate Multiple Targets Associated with Amyloid-β Precursor Protein Processing and Amyloid-β Protein Clearance
Patil, S. P., Maki, S., Khedkar, S. A., Rigby, A. C., & Chan, C. (2010) · Journal of Natural Products · doi:10.1021/np900633j · Cited by 92
SUMO and Alzheimer’s Disease
Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., & Fraser, P. E. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8257-7 · Cited by 94
The ‘O-acyl isopeptide method’ for the synthesis of difficult sequence-containing peptides: application to the synthesis of Alzheimer's disease-related amyloid β peptide (Aβ) 1-42
Sohma, Y., Hayashi, Y., Kimura, M., Chiyomori, Y., Taniguchi, A., Sasaki, M., Kimura, T., & Kiso, Y. (2005) · Journal of Peptide Science · doi:10.1002/psc.649 · Cited by 90
Low‐n oligomers as therapeutic targets of Alzheimer’s disease
Ono, K., & Yamada, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07187.x · Cited by 76
Fulvic Acid Inhibits Aggregation and Promotes Disassembly of Tau Fibrils Associated with Alzheimer's Disease
Cornejo, A., Jiménez, J. M., Caballero, L., Melo, F., & Maccioni, R. B. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110623 · Cited by 89
pH-Dependent Amyloid and Protofibril Formation by the ABri Peptide of Familial British Dementia
Srinivasan, R., Jones, E. M., Liu, K., Ghiso, J. A., Marchant, R. E., & Zagorski, M. G. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.001 · Cited by 89
A Possible Role for Cathepsins D, E, and B in the Processing of β‐amyloid Precursor Protein in Alzheimer's Disease
Mackay, E. A., Ehrhard, A., Moniatte, M., Guénet, C., Tardif, C., Tarnus, C., Sorokine, O., Heintzelmann, B., Nay, C., Rémy, J.-M., et al. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00414.x · Cited by 89
Fibril formation and neurotoxicity by a herpes simplex virus glycoprotein B fragment with homology to Alzheimer’ β amyloid peptide
Azizeh, B. Y., Cribbs, D. H., Cotman, C. W., & LaFerla, F. M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46881-6_287 · Cited by 88
Self-citation
All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids
Cribbs, D. H., Pike, C. J., Weinstein, S. L., Velázquez, P., & Cotman, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7431 · Cited by 89
Self-citation
The Ability of Amyloid β‐Protein [AβP (1–40)] to Form Ca2+ Channels Provides a Mechanism for Neuronal Death in Alzheimer's Disease
Arispe, N. J., Pollard, H. B., & Rojas, E. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44414.x · Cited by 89
Aβ40 Protects Non-toxic Aβ42 Monomer from Aggregation
Yan, Y., & Wang, C. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.014 · Cited by 99
Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A
Willén, K., Edgar, J. R., Hasegawa, T., Tanaka, N., Futter, C. E., & Gouras, G. K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0203-y · Cited by 86
An update on clinical proteomics in Alzheimer’s research
Korolainen, M. A., Nyman, T. A., Aittokallio, T. A., & Pirttilä, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06558.x · Cited by 88
Free radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 87
Development of O ‐acyl isopeptide method
Sohma, Y., Yoshiya, T., Taniguchi, A., Kimura, T., Hayashi, Y., & Kiso, Y. (2007) · Biopolymers · doi:10.1002/bip.20683 · Cited by 86
Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid
Pike, C. J., & Cotman, C. W. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90331-9 · Cited by 86
Self-citation
Inside the diabetic brain: Insulin resistance and molecular mechanism associated with cognitive impairment and its possible therapeutic strategies
Dutta, B. J., Singh, S., Seksaria, S., Gupta, G. D., & Singh, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106358 · Cited by 89
Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
Vogt, A. S., Jennings, G. T., Mohsen, M. O., Vogel, M., & Bachmann, M. F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043895 · Cited by 88
γ-Secretase Catalyzes Sequential Cleavages of the AβPP Transmembrane Domain
Xu, X. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0957 · Cited by 84
Familial Alzheimer’s mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site
Chen, W., Gamache, E., Rosenman, D. J., Xie, J., López, M. M., Li, Y., & Wang, C. (2014) · Nature Communications · doi:10.1038/ncomms4037 · Cited by 85
Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases
Hickman, D. T., López-Deber, M. P., Ndao, D. M., Silva, A. B., Nand, D., Pihlgren, M., Giriens, V., Madani, R., St-Pierre, A., Karastaneva, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186338 · Cited by 84
Effects of the mutations Glu22 to Gln and Ala21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide
Clements, A., Walsh, D. M., Williams, C. H., & Allsop, D. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90129-9 · Cited by 83
Solution Structure Model of Residues 1−28 of the Amyloid β-Peptide When Bound to Micelles
Marcinowski, K. J., Shao, H., Clancy, E. L., & Zagorski, M. G. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9738687 · Cited by 81
Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APPSWE
Savonenko, A. V., Xu, G. M., Price, D. L., Borchelt, D. R., & Markowska, A. L. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00012-8 · Cited by 63
Processing of Amyloid Precursor Protein in Human Primary Neuron and Astrocyte Cultures
LeBlanc, A. C., Papadopoulos, M., Bélair, C., Chu, W. N., Crosato, M., Powell, J., & Goodyer, C. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031183.x · Cited by 80
Polyclonals to β-amyloid(1–42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum
Mak, K., Yang, F., Vinters, H. V., Frautschy, S. A., & Cole, G. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91725-6 · Cited by 80
β-Amyloid peptides induce degeneration of cultured rat microglia
Korotzer, A. R., Pike, C. J., & Cotman, C. W. (1993) · Brain Research · doi:10.1016/0006-8993(93)90068-x · Cited by 82
Self-citation
In Silico Study of Full-Length Amyloid β 1−42 Tri- and Penta-Oligomers in Solution
Masman, M. F., Eisel, U. L. M., Csizmadia, I. G., Penke, B., Enriz, R. D., Marrink, ‪. J., & Luiten, P. G. M. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp901057w · Cited by 81
Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1Q
Webster, S. D., O’Barr, S. A., & Rogers, J. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390412 · Cited by 81
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 81
Apolipoprotein E enhances uptake of soluble but not aggregated amyloid‐β protein into synaptic terminals
Gylys, K. H., Fein, J. A., Tan, A. M., & Cole, G. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01643.x · Cited by 70
Amyloidosis of Alzheimer's Aβ peptides: solid‐state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies
Antzutkin, O. N. (2004) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1341 · Cited by 80
Rapid aggregation and assembly in aqueous solution of Aβ (25–35) peptide
Millucci, L., Raggiaschi, R., Franceschini, D., Terstappen, G. C., & Santucci, A. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0033-3 · Cited by 79
Design and synthesis of a novel water-soluble Aβ1-42 isopeptide: an efficient strategy for the preparation of Alzheimer's disease-related peptide, Aβ1-42, via O–N intramolecular acyl migration reaction
Sohma, Y., Sasaki, M., Hayashi, Y., Kimura, T., & Kiso, Y. (2004) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.06.059 · Cited by 81
Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer’s pathology: Insights and therapeutic approaches from periphery
Ullah, R., Park, T. J., Huang, X., & Kim, M. O. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101451 · Cited by 78
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR‐α, PPAR‐γ and TRPV1, but not CB1 or CB2 receptors
Benito, C., Tolón, R. M., Castillo, A. I., Ruiz‐Valdepeñas, L., Martínez-Orgado, J. A., Fernández, J., Vázquez, C., Cravatt, B. F., & Romero, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01889.x · Cited by 81
Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches
Soto, C. A. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050371 · Cited by 78
Cathepsin D displays in vitro β-secretase-like specificity
Chevallier, N., Vizzavona, J., Marambaud, P., Baur, C.-P., Spillantini, M. G., Fulcrand, P., Martínez, J., Goedert, M., Vincent, J., & Checler, F. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01330-3 · Cited by 78
Oxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome
Head, E., Garzon-Rodriguez, W., Johnson, J. K., Lott, I. T., Cotman, C. W., & Glabe, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0431 · Cited by 75
Self-citation
A Distinct ER/IC γ-Secretase Competes with the Proteasome for Cleavage of APP
Skovronsky, D., Pijak, D. S., Doms, R. W., & Lee, V. M. ‐. (1999) · Biochemistry · doi:10.1021/bi991728z · Cited by 76
Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Cameron, B., Tse, W., Lamb, R., Li, X., Lamb, B. T., & Landreth, G. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1729-12.2012 · Cited by 76
Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified γ-Secretase Complexes
Cacquevel, M., Aeschbach, L., Houacine, J., & Fraering, P. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035133 · Cited by 75
Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?
Echeverría, V., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:299 · Cited by 81
The N-Terminal Region of Amyloid β Controls the Aggregation Rate and Fibril Stability at Low pH through a Gain of Function Mechanism
Brännström, K., Öhman, A., Nilsson, L., Pihl, M., Sandblad, L., & Olofsson, A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503535m · Cited by 74
Copper(II) interaction with amyloid-β: Affinity and speciation
Arena, G., Pappalardo, G., Sóvágó, I., & Rizzarelli, E. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.07.012 · Cited by 74
Methods for Analysis of Amyloid-β Aggregates
Bruggink, K. A., Müller, M., Kuiperij, H. B., & Verbeek, M. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111421 · Cited by 76
ON intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence‐containing bioactive peptides
Sohma, Y., Hayashi, Y., Skwarczyński, M., Hamada, Y., Sasaki, M., Kimura, T., & Kiso, Y. (2004) · Biopolymers · doi:10.1002/bip.20136 · Cited by 74
Structure of Aβ(25–35) Peptide in Different Environments
Shanmugam, G., & Polavarapu, P. L. (2004) · Biophysical Journal · doi:10.1529/biophysj.104.040907 · Cited by 74
Amyloid β-Protein Aggregation Nullifies Its Pathologic Properties in Cultured Cerebrovascular Smooth Muscle Cells
Davis-Salinas, J., & Nostrand, W. E. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20887 · Cited by 74
Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1
Johnson, E. C. B., Ho, K., Yu, G.-Q., Das, M., Sanchez, P. E., Djukic, B., Lopez, I., Yu, X., Gill, M., Zhang, W., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00393-5 · Cited by 73
Simvastatin prevents β-amyloid25–35-impaired neurogenesis in hippocampal dentate gyrus through α7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate
Wang, C., Chen, T., Li, G., Zhou, L., Sha, S., & Chen, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.020 · Cited by 75
Intracerebral /sB-amyloid(25–35) produces tissue damage: Is it neurotoxic?
Rush, D. K., Aschmies, S., & Merriman, M. C. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90061-2 · Cited by 72
P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.
Higgins, L. S., Murphy, G. M., Forno, L. S., Catalano, R., & Cordell, B. (1996) · Europe PMC (PubMed Central) · Cited by 70
Prion-like seeding and nucleation of intracellular amyloid-β
Olsson, T. T., Klementieva, O. L., & Gouras, G. K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.015 · Cited by 74
The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease
Bernstein, H., Kirschke, H., Wiederanders, B., Kh, P., Zipress, A., & Rinne, A. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815106 · Cited by 70
Cross‐linking of a synthetic partial‐length (1–28) peptide of the Alzheimer β/A4 amyloid protein by transglutaminase
Ikura, K., Takahata, K., & Sasaki, R. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81772-r · Cited by 70
Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease
Storck, S. E., & Pietrzik, C. U. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2267-3 · Cited by 74
New Insights into the Roles of Metalloproteinases in Neurodegeneration and Neuroprotection
Turner, A. J., & Nalivaeva, N. N. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82006-x · Cited by 71
The coexistence of an equal amount of Alzheimer's amyloid‐β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway
Chang, Y., & Chen, Y. (2014) · FEBS Journal · doi:10.1111/febs.12813 · Cited by 68
Intrinsically Disordered Proteins: Where Computation Meets Experiment
Burger, V., Gurry, T., & Stultz, C. M. (2014) · Polymers · doi:10.3390/polym6102684 · Cited by 71
Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate β-amyloid(25–35) induced neurodegeneration in cultured hippocampal neurons
Woods, A. G., Cribbs, D. H., Whittemore, E. R., & Cotman, C. W. (1995) · Brain Research · doi:10.1016/0006-8993(95)00775-l · Cited by 56
Self-citation
Effect of acid predissolution on fibril size and fibril flexibility of synthetic beta-amyloid peptide
Shen, C. L., Fitzgerald, M., & Murphy, R. M. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80593-4 · Cited by 71
Metallothionein-III Antagonizes the Neurotoxic and Neurotrophic Effects of Amyloid β Peptides
Irie, Y., & Keung, W. M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4594 · Cited by 70
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model
Meister, S., Zlatev, I., Stäb, J., Docter, D., Baches, S., Stauber, R. H., Deutsch, M., Schmidt, R., Ropele, S., Windisch, M., et al. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt225 · Cited by 73
Surface Plasmon Resonance Analysis of Alzheimer's β-Amyloid Aggregation on a Solid Surface: From Monomers to Fully-Grown Fibrils
Ryu, J., Joung, H., Kim, M., & Park, C. B. (2008) · Analytical Chemistry · doi:10.1021/ac7019514 · Cited by 68
Mechanism of docosahexaenoic acid‐induced inhibition of in vitro Aβ1–42 fibrillation and Aβ1–42‐induced toxicity in SH‐S5Y5 cells
Hossain, S., Hashimoto, M., Katakura, M., Miwa, K., Shimada, T., & Shido, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06336.x · Cited by 70
Sleep deficits in mild cognitive impairment are related to increased levels of plasma amyloid-β and cortical thinning
Sanchez-Espinosa, M. P., Atienza, M., & Cantero, J. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.05.027 · Cited by 70
Differential physiologic responses of α7 nicotinic acetylcholine receptors to β‐amyloid1–40 and β‐amyloid1–42
Lee, D. H. S., & Wang, H.-Y. (2003) · Journal of Neurobiology · doi:10.1002/neu.10203 · Cited by 67
Anti-amnesic effect of neurosteroid PREGS in Aβ25–35-injected mice through σ1 receptor- and α7nAChR-mediated neuroprotection
Yang, R., Chen, L., Wang, H., Xu, B., Tomimoto, H., & Chen, L. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.035 · Cited by 67
“Click Peptides”—Chemical Biology‐Oriented Synthesis of Alzheimer's Disease‐Related Amyloid β Peptide (Aβ) Analogues Based on the “O‐Acyl Isopeptide Method”
Sohma, Y., & Kiso, Y. (2006) · ChemBioChem · doi:10.1002/cbic.200600112 · Cited by 70
Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling
Brockhaus, M., Grünberg, J., Röhrig, S., Loetscher, H., Wittenburg, N., Baumeister, R., Jacobsen, H., & Haass, C. (1998) · Neuroreport · doi:10.1097/00001756-199805110-00043 · Cited by 67
Signaling effect of amyloid-β42 on the processing of AβPP
Tabaton, M., Zhu, X., Perry, G. L., Smith, M. A., & Giliberto, L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.002 · Cited by 74
Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)
Belluti, F., Rampa, A., Gobbi, S., & Bisi, A. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.772983 · Cited by 68
Direct interaction of soluble human recombinant tau protein with Aβ 1–42 results in tau aggregation and hyperphosphorylation by tau protein kinase II
Rank, K. B., Pauley, A. M., Bhattacharya, K., Wang, Z., EVANS, D. B., Fleck, T. J., Johnston, J. A., & Sharma, S. K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02376-1 · Cited by 66
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
Liu, J., Yang, B., Ke, J., Li, W., & Suen, W.-C. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0406-x · Cited by 67
Amyloid β 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs
Wısnıewskı, T., Lalowski, M. M., Bobik, M., RUSSELL, M., Strosznajder, J. B., & Frangione, B. (1996) · Biochemical Journal · doi:10.1042/bj3130575 · Cited by 66
Mitigating Alzheimer’s Disease with Natural Polyphenols: A Review
Gaudreault, R., & Mousseau, N. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190315093520 · Cited by 65
Environment‐ and mutation‐dependent aggregation behavior of Alzheimer amyloid β‐protein
Yamamoto, N., Hasegawa, K., Matsuzaki, K., Naiki, H., & Yanagisawa, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02459.x · Cited by 67
The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
Amijee, H., & Scopes, D. I. C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1044 · Cited by 65
Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome
Cárdenas, A. M., Ardiles, Á. O., Barraza, N., Báez‐Matus, X., & Caviedes, P. A. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.012 · Cited by 68
Comparative Molecular Dynamics Studies of Wild-Type and Oxidized Forms of Full-Length Alzheimer Amyloid β-Peptides Aβ(1−40) and Aβ(1−42)
Triguero, L., Singh, R. R. P., & Prabhakar, R. S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp801168v · Cited by 62
Cu2+ accentuates distinct misfolding of Aβ(1–40) and Aβ(1–42) peptides, and potentiates membrane disruption
Matheou, C. J., Younan, N. D., & Viles, J. H. (2014) · Biochemical Journal · doi:10.1042/bj20141168 · Cited by 64
Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Coskuner‐Weber, O., & Uversky, V. N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020336 · Cited by 71
Perspectives on the Amyloid-β Cascade Hypothesis
Lee, H., Casadesús, G., Zhu, X., Joseph, J. A., Perry, G. L., & Smith, M. A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6205 · Cited by 66
Pathogenic amyloid β-protein induces apoptosis in cultured human cerebrovascular smooth muscle cells
Davis, J., Cribbs, D. H., Cotman, C. W., & Nostrand, W. E. V. (1999) · Amyloid · doi:10.3109/13506129909007321 · Cited by 64
Self-citation
Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer’s type
Harman, D. (1993) · AGE · doi:10.1007/bf02436127 · Cited by 63
The dark sides of amyloid in Alzheimer's disease pathogenesis
Sorrentino, P., Iuliano, A., Polverino, A., Jacini, F., & Sorrentino, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.12.038 · Cited by 64
Quartz crystal microbalance analysis of growth kinetics for aggregation intermediates of the amyloid-β protein
Kotarek, J. A., Johnson, K. C., & Moss, M. A. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.03.022 · Cited by 62
Intrahippocampal injection of Aβ 1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain
Zheng, M., Liu, J., Ruan, Z., Tian, S., Ma, Y., Zhu, J., & Li, G. (2013) · Amyloid · doi:10.3109/13506129.2012.755122 · Cited by 62
GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer’s disease
Audoy-Rémus, J., Bozoyan, L., Dumas, A., Filali, M., Lecours, C., Lacroix, S., Rivest, S., Tremblay, M., & Vallières, L. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.010 · Cited by 63
Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid β(1–42)
Fan, Q., Liu, Y., Wang, X., Zhang, Z., Fu, Y., Liu, L., Wang, P., Ma, H., Ma, H., Seeram, N. P., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00673 · Cited by 62

Authors: Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C.
Affiliations: University of California, Irvine (US)
ORCID: Henschen, A
Yates, J
Cotman, C
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1992-01
Volume: 267
Issue: 1
Pages: 546-554
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1016/s0021-9258(18)48529-8
OpenAlex: W2130144581
Cited by: 1,014
References: 42
Citations by year: 2026: 7 · 2025: 8 · 2024: 14 · 2023: 21 · 2022: 14 · 2021: 29 · 2020: 20 · 2019: 22 · 2018: 28 · 2017: 27 · 2016: 30 · 2015: 29 · 2014: 37 · 2013: 29 · 2012: 31
FWCI: 28.77
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 10516 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: National Institutes of Health (1r35ag007918-01, 5r01hd021379-14)
National Institute on Aging (AG07918)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD21379)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
Keywords: amyloid-beta, Alzheimer's disease, peptide analogues, amyloid fibril formation, peptide aggregation, solubility, pH dependence, Congo red staining, thioflavin T staining, amyloid plaques, hexafluoroisopropanol, amyloid deposition
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Amyloid, Chromatography, High Pressure Liquid, Electrophoresis, Polyacrylamide Gel, Hydrogen-Ion Concentration, Kinetics, Microscopy, Electron, Molecular Sequence Data, Peptides, Mass Spectrometry, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks